Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial

The multi-center, randomized, open-label, phase III trial discussed in the present study was performed to compare the clinical outcomes of nedaplatin (NDP) plus paclitaxel, and carboplatin (CBP) plus paclitaxel for the treatment of epithelial ovarian cancer (EOC). In the current study, 182 patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Li, Li, Zhuang, Qingqing, Cao, Zeyi, Yin, Rutie, Zhu, Yaping, Zhu, Lirong, Xie, Xing, Zhang, Youzhong, Wu, Qiang, Zheng, Jianhua, Zhou, Qi, Li, Xiaoping, Wu, Lingying, Feng, Youji, Wang, Changyu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796383/
https://ncbi.nlm.nih.gov/pubmed/29467885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados